
HTGF and STIFT invest in JeNaCell
High-Tech Gründerfonds (HTGF) and The Thüringen Foundation for Technology Innovation and Research (STIFT) have invested €700,000 in German biomaterial developer JeNaCell.
The start-up company will use the funding to optimise its lead product and facilitate large quantity production following the product's entry into the market.
HTGF typically invests €500,000 in seed rounds followed by a potential follow-up investment of up to €1.5m.
Company
JeNaCell spun out of the Institute for Technical and Environmental Chemistry at the Friedrich Schiller University in Jena in June 2012.
The company has developed a biomaterial for application in medicine, cosmetics and technology. It also plans to enter industry partnerships by offering its product to be used in other product developments.
People
Martin Pfister worked on the deal as investment manager at HTGF.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater